(PBH) Prestige Brand Holdings - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74112D1019
PBH: Pain Relievers, Skincare, Eye Care, Dental Care, Digestive Aid
Prestige Consumer Healthcare Inc. (NYSE:PBH) operates as a developer, manufacturer, and distributor of over-the-counter (OTC) health and personal care products. The company serves markets in North America, Australia, and other international regions, organizing its operations into two primary segments: North American OTC Healthcare and International OTC Healthcare. Its product portfolio includes a wide range of well-known brands that address common health and personal care needs.
The company’s offerings span multiple health categories, including pain relief, digestive health, and skincare. Under the BC and Goodys brands, it provides analgesic powders. The Boudreauxs Butt Paste brand specializes in diaper rash treatments and skin protectants. For throat and mouth pain, the Chloraseptic brand offers sprays and lozenges. Clear Eyes is its line of eye care products designed to alleviate redness and irritation. The Compound W brand focuses on at-home wart removal, while Debrox is dedicated to ear wax removal.
Additional products include dental care items under the DenTek brand, such as dental guards and floss picks. Dramamine is its solution for motion sickness. The Fleet brand covers enemas and laxatives, while Gaviscon is aimed at treating upset stomachs. Ludens provides cough drops, and Monistat addresses yeast infections in women. The Nix brand offers treatments for lice and parasites. Feminine care products are available under the Summers Eve brand, and TheraTears focuses on dry eye relief. The Fess brand offers nasal saline sprays and washes, and Hydralyte is its oral rehydration solution.
Distribution channels include mass merchandisers, drug stores, food retailers, dollar stores chains, convenience stores, and e-commerce platforms. This broad reach ensures accessibility for its products across various consumer segments. The company, formerly known as Prestige Brands Holdings, Inc., rebranded to Prestige Consumer Healthcare Inc. in August 2018, reflecting its focus on healthcare products. Founded in 1996, it is headquartered in Tarrytown, New York.
Financially, Prestige Consumer Healthcare Inc. has a market capitalization
Additional Sources for PBH Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PBH Stock Overview
Market Cap in USD | 4,410m |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
GiC Sub-Industry | Pharmaceuticals |
IPO / Inception | 2005-02-10 |
PBH Stock Ratings
Growth 5y | 88.6% |
Fundamental | 52.9% |
Dividend | 0.30% |
Rel. Strength Industry | 10.6 |
Analysts | 3.88/5 |
Fair Price Momentum | 90.21 USD |
Fair Price DCF | 116.00 USD |
PBH Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 1.0% |
PBH Growth Ratios
Growth Correlation 3m | 56% |
Growth Correlation 12m | 76.3% |
Growth Correlation 5y | 90.5% |
CAGR 5y | 22.27% |
CAGR/Max DD 5y | 0.86 |
Sharpe Ratio 12m | 0.15 |
Alpha | 4.80 |
Beta | 0.33 |
Volatility | 24.95% |
Current Volume | 262.5k |
Average Volume 20d | 359.5k |
As of March 14, 2025, the stock is trading at USD 82.83 with a total of 262,472 shares traded.
Over the past week, the price has changed by -4.89%, over one month by -3.33%, over three months by +0.64% and over the past year by +10.34%.
Partly, yes. Based on ValueRay Fundamental Analyses, Prestige Brand Holdings (NYSE:PBH) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 52.90 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PBH as of March 2025 is 90.21. This means that PBH is currently overvalued and has a potential downside of 8.91%.
Prestige Brand Holdings has received a consensus analysts rating of 3.88. Therefor, it is recommend to buy PBH.
- Strong Buy: 4
- Buy: 0
- Hold: 3
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, PBH Prestige Brand Holdings will be worth about 97.6 in March 2026. The stock is currently trading at 82.83. This means that the stock has a potential upside of +17.88%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 89.1 | 7.6% |
Analysts Target Price | 85.3 | 3% |
ValueRay Target Price | 97.6 | 17.9% |